| Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022) |
|---|
| 08/13/2009 | US20090203668 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/13/2009 | US20090203666 Compounds and compositions as hedgehog pathway modulators |
| 08/13/2009 | US20090202521 Bifunctional Polyazamacrocyclic Chelating Agents |
| 08/11/2009 | US7572783 Obesity; N-(1-benzyl-piperidin-4-yl)-2-(2,5-dioxo-7-phenoxy-1,2,3,5-tetrahydro-benzo[e][1,4]diazepin-4-yl)-3-methyl-butyramide; modulators of ghrelin receptor (GHSR) |
| 08/05/2009 | EP2085392A1 Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide |
| 08/05/2009 | EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 08/05/2009 | EP1742707A4 Treatment of cns disorders using cns target modulators |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/23/2009 | WO2009053742A3 Salts of nefopam and their use in therapy |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/22/2009 | CN100516022C Process for production of high-purity enamines |
| 07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/02/2009 | WO2009080725A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip) |
| 07/02/2009 | CA2710130A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/18/2009 | WO2009075691A1 Cb-1 modulating compounds and their use |
| 06/11/2009 | WO2009071631A2 Dibenzoazepine and dibenzooxazepine trpa1 agonists |
| 06/11/2009 | US20090149442 Atypical antipsychotic agents having low affinity for the D2 receptor |
| 06/11/2009 | CA2706903A1 Dibenzoazepine and dibenzooxazepine trpa1 agonists |
| 06/09/2009 | US7544678 Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) |
| 06/04/2009 | US20090143357 Heteroaryl urea derivatives useful for inhibiting chk1 |
| 06/03/2009 | CN101448799A Racemisation of enantiomers of nefopam and analogues |
| 05/28/2009 | US20090137467 Bipartite Inhibitors of Bacterial RNA Polymerase |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN101443014A Chemical compounds |
| 05/27/2009 | CN100491333C Process for production of high-purity enamines |
| 05/21/2009 | US20090131401 Transcription factor modulating compounds and methods of use thereof |
| 05/07/2009 | WO2009055917A1 Inhibitors of histone deacetylase |
| 05/07/2009 | US20090118497 Crystallization Process of Quetiapine Hemifumarate |
| 05/07/2009 | CA2703718A1 Inhibitors of histone deacetylase |
| 04/29/2009 | EP1651592B1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/29/2009 | CN100482221C Use of nefopam for the treatment of nausea or emesis |
| 04/23/2009 | US20090105301 9a-substituted azalides for the treatment of malaria |
| 04/23/2009 | US20090105216 3- (aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors |
| 04/16/2009 | WO2008059516A3 Process for purification of macrolides |
| 04/16/2009 | US20090099252 Novel laulimalide analogues as therapeutic agents |
| 04/15/2009 | EP2046739A1 Substituted aniline derivatives |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | US7517871 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/09/2009 | US20090093455 Quinolone analogs and methods related thereto |
| 04/02/2009 | US20090088416 Deuterium-enriched lapaquistat |
| 03/26/2009 | WO2005084295A3 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3 |
| 03/26/2009 | US20090082560 Aminodihydrothiazine derivatives |
| 03/26/2009 | US20090082386 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 03/26/2009 | US20090082333 Remedy for xanthoma |
| 03/24/2009 | US7507816 Compounds for treatment of inflammation, antidepressants, nervous system disorders, cardiovascular disorders or analgesics from mannich reaction |
| 03/19/2009 | US20090075971 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same |
| 03/12/2009 | US20090069291 Salt Forms |
| 03/11/2009 | CN100467457C A process for the resolution of nefopam |
| 03/04/2009 | EP2029555A2 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same |
| 03/04/2009 | CN101379044A Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 02/25/2009 | EP2027099A2 Racemisation of enantiomers of nefopam and analogues |
| 02/19/2009 | WO2008106128A3 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 02/19/2009 | US20090048221 Conjugates with Anti-Inflammatory Activity |
| 02/12/2009 | US20090042875 Substituted heterocyclic compounds and uses thereof |
| 02/05/2009 | US20090036425 Substituted bicyclolactam compounds |
| 02/04/2009 | CN101360725A Solid formulations |
| 02/04/2009 | CN101360724A Salt forms |
| 01/29/2009 | US20090029965 Vasopressin V1a Antagonists |
| 01/29/2009 | US20090029426 Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies |
| 01/28/2009 | CN101355950A Rifamycin analogs and uses thereof |
| 01/27/2009 | US7482448 Compounds and compositions as cathepsin inhibitors |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/08/2009 | US20090012178 Benzoxazocines and Their Therapeutic Use |
| 01/06/2009 | US7473796 Maytansinoid intermediates: N-alkyl- or aryldithioalkanoylalanines and N-alkanoyl- or aroylthioalkanoylalanines, e.g., N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine; optical isomers and racemic mixtures; preparations from isobutylene sulfide and acetonitrile, methyl methanethiosulfonate, etc. |
| 12/18/2008 | US20080311609 Novel Molecular Probes |
| 12/03/2008 | EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 12/03/2008 | EP1996202A1 Chemical compounds |
| 11/20/2008 | US20080287419 Apoptosis promoters |
| 11/18/2008 | CA2516557C Triazole compounds useful in therapy |
| 11/13/2008 | WO2008135488A1 Aspartyl protease inhibitors |
| 11/13/2008 | US20080280881 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 10/30/2008 | WO2008130566A1 Nitroxyl ion source with second order reaction nitroxyl release |
| 10/30/2008 | US20080269302 Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 10/29/2008 | CN100429206C Benzoxazine derivatives as 5-HT6 modulators and uses thereof |
| 10/23/2008 | US20080262012 polymorphic forms alpha , beta and gamma; for the oral or topical route; In case of invasive bacteria, it may be useful to use the most bioavailable polymorphic form, whereas in case of non-invasive pathogens it may be more appropriate to use the less adsorbed forms, since they are safer |
| 10/23/2008 | US20080261949 ethyl 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; tocolytics; delaying preterm birth; antidiabetic; obesity; oxyalkylation of the phenyl(alkyl)cyclohexyl(alkyl)amine with a glycidyl ether |
| 10/16/2008 | US20080255346 Ratiometric fluorescent chemosensor for selective detection of Hg (II) ions |
| 10/16/2008 | US20080255088 DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS |
| 10/09/2008 | US20080249124 Conjugate linkage is removable upon administration; 41-Desmethoxyrapamycin-L-wortmannin; antineoplastic agents |
| 10/09/2008 | US20080249123 Wortmannin-rapamycin conjugate and uses thereof |
| 10/07/2008 | US7432074 Method for extracting a macrolide from biomatter |
| 09/30/2008 | US7429565 Antiviral phosphonate analogs |
| 09/25/2008 | US20080234247 Heterocyclic analgesic compounds and methods of use thereof |
| 09/25/2008 | US20080233169 Implantable medical device having a coating of a biocompatible polylactone from N-substituted 4-aza-caprolactone |
| 09/18/2008 | WO2007104933A8 Chemical compounds |
| 09/18/2008 | US20080227770 Benzoxazepine Compound |
| 09/16/2008 | US7425550 Lactam glycogen phosphorylase inhibitors and method of use |
| 09/12/2008 | WO2008109577A1 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid s,s dioxide and methods of making and using the same |
| 09/12/2008 | WO2008108445A1 Benzoxazepine derivatives and use thereof |
| 09/11/2008 | US20080221158 Novel 14 and 15 Membered Ring Compounds |
| 09/11/2008 | US20080221142 useful in interfering with the life cycle of bacteria and in treating or preventing a bacterial infection |
| 09/04/2008 | WO2008106128A2 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 09/04/2008 | CA2678577A1 Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 09/03/2008 | CN101258136A New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-HT6 mediated disorders such as alzheimer s desease, cognitive disorders, co |
| 09/03/2008 | CN101258135A New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-HT6 mediated disorders such as alzheimer desease, cognitive disorders, cogn |